Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...

While patients with acute myeloid leukemia (AML) are routinely treated with chemotherapy and other cell-killing therapies, existing options do not lead to favorable clinical outcomes in all patients.

The evolving treatment landscape for unfit patients with newly diagnosed acute myeloid leukemia (AML) centers on venetoclax combination and personalized strategies. Management of newly diagnosed acute ...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be ...

Infantile ALL occurs in children under age one. It’s a rare and aggressive leukemia that typically has a poor outlook. Treatment involves chemo and sometimes a stem cell transplant. Leukemia refers to ...

Blinatumomab significantly improved disease-free survival in children with B-ALL, with a 61% increase, establishing a new standard for treatment. Hispanic children, who have higher B-ALL rates, ...

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem ...

Acute myeloid leukemia is the most common type of leukemia in adults and the resulting chemotherapy treatment can put patients at an increased risk for cardiac damage. Associate Professor of Medicine ...